Navigating the way to a positive HTA: avoiding snakes, climbing ladders
Hayward Medical Communications reports on how industry can avoid the ‘snakes’ by climbing strategic ‘ladders’ to achieve health technology assessment success
Health technology assessment (HTA) outcomes can
make, or break, a product’s fate; depending on the HTA body’s remit, outcome
decisions can affect a technology’s reimbursement status or position within a
clinical pathway, and/or directly influence the price negotiation process. With
such high stakes riding on HTA results, a timely, evidence-based and
country-specific approach must be adopted. Read more from Hayward Medical
Communications, an expert agency that partners with pharmaceutical, device and
diagnostics companies to deliver effective market access strategies.